StockData
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) stock

AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.40−0.08 (-0.52%)

Close on Nov 17, 2026Market cap $2.06BP/E 6.7Yield –

Aurinia Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aurinia Pharmaceuticals's price to book ratio was 3.5× on Nov 11, 2026, against 5.8× a year earlier. Over the last 5 years it ranged from 1.4× to 9.9×, with a median of 3.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.5×−2.2
2025Dec 31, 20255.7×+2.4
2024Dec 31, 20243.3×+0.0
2023Dec 29, 20233.3×+1.8
2022Dec 30, 20221.4×−8.5
2021Dec 31, 20219.9×+4.8
2020Dec 31, 20205.2×−7.6
2019Dec 31, 201912.8×+9.8
2018Dec 31, 20182.9×–

More Aurinia Pharmaceuticals figures

See a number that looks wrong?